Revisit the Effects of Fucoidan on Gut Microbiota in Health and Disease: What Do We Know and What Do We Need to Know?

Qingsen Shang
DOI: https://doi.org/10.1016/j.bcdf.2020.100221
2020-01-01
Bioactive Carbohydrates and Dietary Fibre
Abstract:Fucoidan is a highly sulfated polysaccharide which is mainly isolated from marine brown seaweeds. During the past decades, fucoidan has been the focus of intense research due to its multifunctional properties and profound clinical significance. Today, oral preparations of fucoidan are widely used as therapeutic drugs and dietary supplements in China, Australia, Russia, South Korea and Japan. Accumulating evidence indicates that dietary fucoidan is not absorbed in the upper gastrointestinal tract. Therefore, when reaching the distal colon, fucoidan would exert a significant effect on gut microbiota. Previous studies have illustrated a remarkable array of beneficial impacts of fucoidan on gut microbiota, however, still we are at the beginning of this research field. In this review article, I revisit the effects of fucoidan on gut microbiota in health and disease and highlight that future studies need to focus on deciphering the structure-activity relationship of fucoidan as a potential prebiotic and demonstrating a causal role of gut microbiota in the treatment of diseases by fucoidan and its associated derivatives.
What problem does this paper attempt to address?